Genetic Studies of Non-Alcoholic Fatty Liver Disease
- Non-alcoholic fatty liver disease is the most common form of liver disease in the United States. It includes many conditions. Researchers want to study fatty liver disease by looking at people who have liver cirrhosis. They also want to look at people who are or were listed for liver transplants. Genetic studies may provide more information on the causes of these conditions.
- To study possible genetic causes of non-alcoholic fatty liver disease.
- Individuals of any age who have non-alcoholic fatty liver disease and related conditions.
- Participants will be screened with a physical exam and medical history.
- Participants will provide a blood sample for genetic testing. Liver tissue from a transplant or biopsy may also be studied.
- Participants may also be asked to have an imaging study of the liver. This imaging study may be an x-ray or magnetic resonance imaging.
- No treatment will be provided as part of this research study.
Non-Alcoholic Fatty Liver Disease
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Genetic Studies of Non-Alcoholic Fatty Liver Disease|
|Study Start Date:||June 2012|
Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common form of liver disease in the United States. It includes a wide spectrum of conditions from benign hepatic steatosis to cirrhosis and liver failure. Non-Alcoholic Steatohepatitis (NASH) is a term that describes specific histological characteristics of liver inflammation and seems to be a determinant step in the progression of NAFLD to cirrhosis and liver failure. The overall purpose of this study is to increase our understanding of the genetic background and pathophysiology of NAFLD through detailed review of physical, radiologic and pathology characteristics, when available. We will perform genetic analysis of known and candidate genes and will assess inheritance through evaluation of unaffected relatives. Most patients will be seen by hepatologists in transplant centers and hepatology clinics across the country. A subset of patients and their families may be seen at the NIH Clinical Center.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01629095
|Contact: Maria J Guillen Sacoto, M.D.||(301) email@example.com|
|Contact: Maximilian Muenke, M.D.||(301) firstname.lastname@example.org|
|United States, California|
|University of California, San Francisco||Recruiting|
|San Francisco, California, United States, 94143|
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike||Recruiting|
|Bethesda, Maryland, United States, 20892|
|Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 email@example.com|
|United States, North Carolina|
|University of North Carolina||Recruiting|
|Chapel Hill, North Carolina, United States, 27599-7030|
|United States, Ohio|
|Cleveland Clinic Transplantation Clinic||Recruiting|
|Cleveland, Ohio, United States|
|United States, Texas|
|Baylor University Medical Center||Recruiting|
|Dallas, Texas, United States|
|Principal Investigator:||Maximilian Muenke, M.D.||National Human Genome Research Institute (NHGRI)|